Zaderej Karen L. 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jul 12, 2024
Insider Transaction Report
Form 4
Zaderej Karen L.
Director
Transactions
- Exercise/Conversion
Common Stock
2024-07-11+2,000→ 4,000 total - Exercise/Conversion
Restricted Stock Units
[F1]2024-07-11−2,000→ 2,000 totalExercise: $0.00→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]The restricted stock units vests in three ratable annual installments beginning July 11, 2023.
Signature
/s/ Ron Honig, Attorney-in-Fact|2024-07-12